| Literature DB >> 30302330 |
Yuvaraj Kavitha1, Arumugam Geetha1.
Abstract
Pancreatitis is characterized by highly morbid inflammation in the pancreas. Currently, there is no specific drug available for pancreatitis except supportive medicines. The present study assessed the pancreato-protective effect of Morus alba root bark extract by using alcohol and cerulein-induced model of pancreatitis. The study also investigated the phytochemical profile through GC-MS and HPLC. Methanolic extract of Morus alba root bark extract (MEMARB) was subjected to GC-MS and HPLC studies. Male albino Wistar rats were administered ethanol (0%-36%) and cerulein (20 μg/kg b.wt. i.p.) with or without MEMARB. Serum lipase, amylase, caspase-1, lipid peroxidation products, glutathione and enzymatic antioxidants were determined. Histological changes in the pancreas were assessed. Cudraflavone B in MEMARB was quantified by HPLC. Significant amount of Cudraflavone B was detected by quantitative HPLC. Marked increase in the levels of serum amylase, lipase, caspase-1, IL-18 and IL-1β were observed in ethanol and cerulein administered rats than in MEMARB co-administered rats. In MEMARB co-administered rats, the antioxidant status was restored to near normal levels. Histological examinations showed that MEMARB significantly reduced the inflammatory and fibrotic changes. The results reveal the potent pancreato-protective effects of Morus alba root bark. The anti-inflammatory effect of Morus alba root bark extract might be due to the presence of various phytonutrients including Cudraflavone B.Entities:
Keywords: AP, acute pancreatitis; AP1, activator protein 1; CP, chronic pancreatitis; Cudraflavone B; DAMPS, damage associated molecular patterns; GC-MS; HPLC; MCP 1, monocyte chemotactic protein 1; MEMARB, methanolic extract of Morus alba root bark; Morus alba; NF-kappa B, nuclear factor kappa-light-chain-enhancer of activated B cells; NLRP3; PSC, pancreatic stellate cell; Pancreatitis; TCP, tropical calcific pancreatitis
Year: 2018 PMID: 30302330 PMCID: PMC6174261 DOI: 10.1016/j.jtcme.2018.01.011
Source DB: PubMed Journal: J Tradit Complement Med ISSN: 2225-4110
List of compounds identified in the methanolic extract of Morus alba root bark by GC-MS.
| No. | RT (min) | Name of the compound | Molecular formula | Molecular Weight (g/mol) | Bioactivity |
|---|---|---|---|---|---|
| 1 | 12.1 | 2H-1-Benzopyran-2-one (Coumarin) | C9H6O2 | 146.14 | Venotonic |
| 2 | 14.5 | Eugenol | C10H12O2 | 164.2 | Improves cell-mediated immunity, local antiseptic |
| 3 | 15.72 | Chrysin | C15H10O4 | 254.24 | Antiinflammatory, antioxidative, anti-hypercholesterolemic |
| 4 | 15.72 | 5,7-dihydroxyisoflavone (Mefenamic acid) | C15H10O4 | 254.23 | Anti-inflammatory, inhibitor of prostaglandin synthesis, analgesic,anti-pyretic |
| 5 | 16.75 | 4′,5,7-Trihydroxy isoflavone (Genistein) | C15H10O5 | 270.24 | Anti-angiogenic, vasculoprotective |
| 6 | 17.1 | Apigenin | C15H10O5 | 270.4 | Anti-inflammatory, anti-proliferative, anti-metastatic |
| 7 | 17.57 | Biochanin A | C16H12O5 | 284.27 | Anti-inflammatory,antidiabetic, anticarcinogenic, lipid metabolism regulator |
| 8 | 17.57 | Pseudobaptigenin | C16H10O5 | 282.24 | Nutrient isoflavone |
| 9 | 17.75 | Rhein (Cassic acid) | C15H8O6 | 284.22 | Anti-microbial, antibiotic, apoptotic, antiproliferative |
| 10 | 18.55 | Morin | C15H10O7 | 302.24 | Anti-inflammatory, antihypertensive, anti-angiogenic, hepatoprotective, neuroprotective |
| 11 | 18.8 | 5,7-dimethoxy flavone | C17H14O4 | 282.29 | Anti-proliferative, apoptotic |
| 12 | 19.7 | Vitamin E | C29H50O2 | 430.71 | Anti-oxidant |
| 13 | 20.63 | 1,6-Heptadiene-3,5 dione,1,7-bis(4-hydroxy-3-methoxy phenyl)-(Curcumin) | C21H20O6 | 368.38 | Anti-inflammatory, anti-oxidant, antimicrobial, anticancer |
| 14 | 20.67 | Vitexin | C21H20O10 | 432.38 | Anti-inflammatory, anti-cancer, neuroprotective |
Pubchem.
Human Metabolome Database (Ref).
Fig. 1Total Ion Chromatogram generated from the GC-MS analysis of the methanolic extract of Morus alba root bark: 1) 2H-1-Benzopyran-2-one (Coumarin) 2) Eugenol 3) 5,7-dihydroxyflavone (Chrysin) 4) 5,7-dihydroxyisoflavone (Mefenamic acid) 5) 4′5,7-Trihydroxy isoflavone (Genistein) 6) 4-H1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- (Apigenin) 7) 4′-methoxy-5,7-dihydroxy isoflavone (Biochanin A) 8) Psi-baptigenin 9) Rhein 10) Morin 11) 5,7-dimethoxy flavone 12) Vitamin E 13) 8-glycosyl apigenin (Vitexin).
Fig. 2High Performance Liquid Chromatography (HPLC) chromatograph of (A) reference standards; (B) Cudraflavone B standard; (C) MEMARB. Conditions: Mobile phase: methanol: acetic acid: water (100:100:1); flow rate: 1.5 ml/min; Run time: 40 min. Wavelength: 270 nm.
Effect of MEMARB on the levels of serum lipase and serum alpha-amylase.
| Group | Lipase (IU/L) | Amylase (IU/L) |
|---|---|---|
| Normal Control | 182 ± 19 | 2732.21 ± 360.65 |
| MEMARB Control | 156 ± 16NS | 2614.02 ± 316.3NS |
| EtOH + Cerulein | 425 ± 50* | 4772.47 ± 629.97* |
| EtOH + Cerulein + MEMARB | 236 ± 31* | 3198.78 ± 422.24* |
Data were analysed by one-way ANOVA followed by post-hoc Bonferroni test. Values are expressed as mean ± S.D. of 6 rats in each group. Statistical significance was calculated by comparing normal control vs. MEMARB control; Control vs. EtOH + Cerulein; EtOH + Cerulein vs. EtOH + Cerulein + MEMARB. *p = 0.000; NS non-significant.
Effect of MEMARB on serum and tissue inflammatory markers.
| Group | Caspase-1 | MPO | IL-1beta | IL-18 | |
|---|---|---|---|---|---|
| Serum (pg/ml) | Pancreas (pM/mg protein) | Pancreas (Units/mg protein) | Serum pg/ml | Serum pg/ml | |
| Normal Control | 12.6 ± 1.8 | 12.6 ± 1.5 | 2.16 ± 0.4 | 15.5 ± 2.6 | 200.5 ± 30.1 |
| MEMARB Control | 11.5 ± 1.3NS | 10.3 ± 1.2NS | 1.82 ± 0.2NS | 13.6 ± 2.1NS | 170 ± 21.6NS |
| EtOH + Cerulein | 21.5 ± 2.8* | 49.6 ± 5.2* | 3.98 ± 0.4* | 31.5 ± 4.5* | 360.5 ± 42* |
| EtOH + Cerulein + MEMARB | 14.3 ± 1.8* | 20.5 ± 2.8* | 2.56 ± 0.3* | 20.5 ± 3.1* | 240 ± 32* |
Data were analysed by one-way ANOVA followed by post-hoc Bonferroni test. Values are expressed as mean ± S.D. of 6 rats in each group. Statistical significance was calculated by comparing normal control vs. MEMARB control; Control vs. EtOH + Cerulein; EtOH + Cerulein vs. EtOH + Cerulein + MEMARB. *p = 0.000; NS non-significant.
Effect of MEMARB on the redox status – levels of TBARS, 4-HNE and reduced glutathione (GSH).
| Group | TBARS (nM/100 mg protein) | 4-HNE (μM/g protein) | GSH (mg/g protein) |
|---|---|---|---|
| Pancreas | Pancreas | Pancreas | |
| Normal Control | 1776.00 ± 225.55 | 2.000 ± 0.24 | 96.015 ± 11.62 |
| MEMARB Control | 1782.40 ± 190.72NS | 2.13 ± 0.21NS | 98.82 ± 12.06NS |
| EtOH + Cerulein | 3408.12 ± 415.8* | 8.100 ± 0.96* | 49.600 ± 6.00* |
| EtOH + Cerulein + MEMARB | 1806.66 ± 229.44* | 5.062 ± 0.60* | 93.330 ± 11.29* |
Data were analysed by one-way ANOVA followed by post-hoc Bonferroni test. Values are expressed as mean ± S.D. of 6 rats in each group. Statistical significance was calculated by comparing normal control vs. MEMARB control; Control vs. EtOH + Cerulein; EtOH + Cerulein vs. EtOH + Cerulein + MEMARB. *p = 0.000; NS non-significant.
Effect of MEMARB on the redox status - Activity levels of antioxidant enzymes.
| Group | GPx (nM GSH consumed/min/mg protein) | SOD (U/mg protein) | Catalase (U/mg protein) |
|---|---|---|---|
| Pancreas | Pancreas | Pancreas | |
| Normal Control | 324.5 ± 42.5 | 14.2 ± 1.49 | 114.4 ± 15.90 |
| MEMARB Control | 339.2 ± 40.02NS | 14.5 ± 1.65NS | 112.1 ± 16.37NS |
| EtOH + Cerulein | 233.6 ± 29.43* | 8.2 ± 0.97* | 72.8 ± 7.79* |
| EtOH + Cerulein + MEMARB | 353.33 ± 46.29* | 11.7 ± 1.51* | 106.3 ± 12.65* |
Data were analysed by one-way ANOVA followed by post-hoc Bonferroni test. Values are expressed as mean ± S.D. of 6 rats in each group. Statistical significance was calculated by comparing normal control vs. MEMARB control; Control vs. EtOH + Cerulein; EtOH + Cerulein vs. EtOH + Cerulein + MEMARB. *p = 0.000; NS non-significant.
Fig. 3Histology of the pancreas (H&E stain, 400X): (a) & (b) Photomicrograph of pancreas from normal control and MEMARB control rats with intact acini and islets. (c) Photomicrograph of pancreas from ethanol and cerulein administered rats showing neutrophil infiltration and fibrosis. (d) Photomicrograph of pancreas from MEMARB co-administered rats showed restored tissue architecture. H&E: Haematoxylin & Eosin; AC: acini; IS: islet; IL & F: inflammation and fibrosis.
Fig. 4Histology of the liver (H&E stain, 400X): (a) & (b) Photomicrograph of liver from normal control and MEMARB control rats with normal tissue structure (c) Photomicrograph of liver from ethanol and cerulein administered rats showing neutrophil infiltration (d) Photomicrograph of liver from MEMARB co-administered rats with reduced inflammatory cell infiltration. H&E: Haematoxylin & Eosin; PT: portal triad; HP: hepatocytes; CV: central vein; IL: inflammation.